High remission rates for new CLL treatment

CLL from a patient and physician perspective

Consent as the basis for using patient data

Your rights as a patient

Privacy and Data Protection within European law

Introduction to medical data protection

The changing landscape of the young investigator meeting at iwCLL 2015

Ethnic variations in CLL prevalence

Risk of bleeding-related adverse events in ibrutinib treated CLL patients

Crystallography of the B-cell receptor immunoglobulin in CLL patients

Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry